Newsroom

May 6, 2021
First quarter GAAP net sales of $1.10 billion , an increase of 3% year-over-year; non-GAAP organic net sales increased 4% year-over-year First quarter GAAP net loss of $16 million versus a net loss of $33 million in the prior year period; first quarter non-GAAP adjusted net income of $29 million ,
May 4, 2021
Pete Perron to focus on deepening Covetrus' relationships with manufacturers to drive better care and outcomes within the veterinary industry. PORTLAND, Maine --(BUSINESS WIRE)--May 4, 2021-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that
March 8, 2021
Veteran talent management executive with tech experience joins global HR leadership team PORTLAND, Maine --(BUSINESS WIRE)--Mar. 8, 2021-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the addition of Stacey M.M.
March 1, 2021
Fourth quarter 2020 net sales of $1.1 billion , an increase of 11% year-over-year, and reported GAAP net loss of $4 million Non-GAAP organic net sales increased 12% year-over-year Non-GAAP adjusted EBITDA increased 19% year-over-year to $56 million Non-GAAP adjusted net income increased 40%
February 24, 2021
Industry leader Link Welborn , DVM, DABVP to serve as veterinary advocate, advancing the Company's focus on veterinarian-led pet care PORTLAND, Maine --(BUSINESS WIRE)--Feb. 24, 2021-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment
February 22, 2021
New hire underscores commitment to enabling better healthcare outcomes via seamless digital and e-commerce experiences between veterinarians and their clients PORTLAND, Maine --(BUSINESS WIRE)--Feb. 22, 2021-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today
January 6, 2021
PORTLAND, Maine --(BUSINESS WIRE)--Jan. 6, 2021-- Covetrus ™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that the Company will participate in the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 .